Comparison of three molecular assays for the detection of rifampin resistance in mycobacterium tuberculosis

Journal of Clinical Laboratory Analysis

Volumn 29, Issue 2, 2015, Pages 142-145

  Moon, Hee Won ^a   Hur, Mina ^a   Kim, Ji Young ^a   Yun, Yeo Min ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Molecular assay; Resistance; Rifampin; Tuberculosis

Indexed keywords

RIFAMPICIN; BACTERIAL PROTEIN; CATALASE; INHA PROTEIN, MYCOBACTERIUM; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASE; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ADVANSURE MDR TB GENOBLOT ASSAY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DRUG SENSITIVITY; HUMAN; IMMUNOASSAY; IMMUNOLOGY TEST KIT; MOLECULAR MODEL; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; SACACE MTB REAL TM RESISTANCE; SENSITIVITY AND SPECIFICITY; XPERT MTB RIF ASSAY; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION; POLYMERASE CHAIN REACTION;

MYCOBACTERIUM TUBERCULOSIS;

BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84925063100     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21742     Document Type: Article

References (16)

1. WHO. 2010/2011 Tuberculosis Global Facts, Geneva: WHO; 2011. Available from: http://www.who.int/tb/publications/2010/factsheet_tb_2010.pdf.
2. WHO. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response, WHO/HTM/TB/2010.3, Geneva: WHO; 2010.
3. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-305.
4. WHO. WHO endorses new rapid tuberculosis test. 2010. Available from: http://www.who.int/mediacentre/news/releases/2010/tb_test_20101208/en/index.html. Accessed 15 June 2011.
5. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-1015.
6. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010;48:229-237.
7. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010;48:2495-2501.
8. Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998;36:1969-1973.
9. Marlowe EM, Novak-Weekley SM, Cumpio J, et al. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 2011;49:1621-1623.
10. Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaitre N. Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 2011;49:1772-1776.
11. Teo J, Jureen R, Chiang D, Chan D, Lin R. Comparison of two nucleic acid amplification assays, the Xpert MTB/RIF and the Amplified Mycobacterium Tuberculosis Direct (MTD) assay, for the detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. J Clin Microbiol 2011;49:3659-3662.
12. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011;184:132-140.
13. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet 2011;377:1495-1505.
14. Scott LE, McCarthy K, Gous N, et al. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: A prospective Study. PLoS Med 2011;8:e1001061.
15. Ioannidis P, Papaventsis D, Karabela S, et al. Cepheid Xpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol 2011;49:3068-3070.
16. Salvo F, Sadutshang TD, Migliori GB, Zumla A, Cirillo DM. Xpert MTB/RIF test for tuberculosis. Lancet 2011;378:481-482; author reply 2-3.